Trending
April 22, 2024

Salubris Biotherapeutics Announces $35 Million in Financing

April 21, 2024

David Nevins Interviews Jorey Berry, CEO of Immune Deficiency Foundation

April 19, 2024

TScan Therapeutics Closes of Upsized Public Offering

April 19, 2024

Bio-Path Holdings Closes of $1.2 Million Registered Direct Offering

April 19, 2024

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

April 19, 2024

Dr. Cathleen Brown Named Medical Director of Winona

April 18, 2024

Verastem Oncology Appoints John Hayslip, M.D., to Chief Medical Officer

April 18, 2024

NRx Pharmaceuticals Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement

April 18, 2024

NRx Pharmaceuticals Prices of $2.0 Million Underwritten Public Offering of Common Stock

April 18, 2024

Soligenix Prices of $4.75 Million Public Offering

April 18, 2024

Biohaven Prices of $230 Million Public Offering of Common Shares

April 18, 2024

Provident Healthcare Partners Advises Community Eye Care Specialists in its Affiliation with EyeSouth Partners

April 18, 2024

Pathios Therapeutics Raises $25M in Series B

April 18, 2024

DrFirst Acquires Myndshft Technologies

April 18, 2024

Planet Fitness Lake Stevens Hosting Grand Opening, Apr. 24

April 18, 2024

Northlane Capital Partners Announces the Sale of VMG Health